HubSpot (NYSE:HUBS) Q4 2025 Earnings call February 11, 2026 04:30 PM ET Speaker4Good afternoon and welcome to HubSpot's Q4 2025 earnings call. My name is Gigi, and I'll be your operator today. At this time, all participant lines are in a listen-only mode, and there will be an opportunity for questions and answers after management's prepared remarks. If you would like to enter the queue for questions, you may do so by dialing * followed by 11 on your telephone keypad. I would now like to hand the conference ...

Ascendis Pharma (NasdaqGS:ASND) Q4 2025 Earnings call February 11, 2026 04:30 PM ET Speaker2Thank you for standing by and welcome to the Ascendis Pharma's fourth quarter 2025 earnings conference call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during this session, you'll need to press star 11 on your telephone. If your question has been answered and you'd like to remove yourself from the queue, simp ...

Biotricity (OTCPK:BTCY) Q3 2026 Earnings call February 11, 2026 04:30 PM ET Speaker1Good afternoon, and welcome to Biotricity's third quarter fiscal 2026 financial results and business update conference call. Today's conference is being recorded. As a reminder, this is Biotricity's third quarter fiscal 2026, ended on December 31, 2025. So all figures presented for this period will reflect that end date. Earlier, Biotricity issued its earnings press release for the period, which highlighted financial and ope ...

AMC Networks (NasdaqGS:AMCX) Q4 2025 Earnings call February 11, 2026 04:30 PM ET Speaker4Good day and thank you for standing by. Welcome to the AMC Networks fourth quarter 2025 earnings call. At this time, all participants are in a listen-only mode. After the speaker's presentation, we'll open up for questions. To ask a question during the session, you need to press star 11 on your telephone. You'll then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 ...

Viking Therapeutics (NasdaqCM:VKTX) Q4 2025 Earnings call February 11, 2026 04:30 PM ET Speaker3Welcome to the Viking Therapeutics fourth quarter and full year 2025 financial results conference call. At this time, all participants will be in a listen-only mode. Following management's prepared remarks, we will hold a Q&A session. To ask a question at that time, please press star key followed by the 1 on your telephone keypad. If anyone has difficulty hearing the conference, please press star, then 0 for oper ...

Neurocrine Biosciences (NasdaqGS:NBIX) Q4 2025 Earnings call February 11, 2026 04:30 PM ET Speaker9Hello and welcome everyone joining today's Neurocrine Biosciences 4th quarter and fiscal year 2025 earnings call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question-and-answer session. To register to ask a question at any time, please press star 1 on your telephone keypad. Please note this call is being recorded. We are standing b ...

Financial Data and Key Metrics Changes - The company ended the first quarter with a cash balance of $5.8 million, down from $6.4 million at the fiscal year-end [3] - Accounts receivable totaled $4.4 million, slightly down from $4.6 million [3] - Inventory increased to $15 million from $14.3 million, reflecting ramped-up production for the XM30 program [3] - Operating cash uses during the quarter were $0.1 million compared to an operating cash generation of $2.8 million in the prior year [5] - Revenue for the first quarter increased 11.6% year-over-year to $9.1 million [6] - Net income totaled $0.2 million, with adjusted EBITDA at $0.7 million [9] Business Line Data and Key Metrics Changes - Optex-Richardson revenue rose 55.9%, driven by higher periscope production and increased XM30 activity [6] - Applied Optics Center (AOC) revenue declined 20.1%, primarily due to lower laser filter and optical assembly volumes [6] - New orders for the quarter totaled $7.9 million, a 31.7% increase year-over-year, with Optex-Richardson orders rising 46.2% [9] Market Data and Key Metrics Changes - Backlog totaled $37.9 million, down from $42 million last year, primarily due to program delays from the 2025 government shutdown [9] - AOC revenues are expected to improve in the second half of fiscal year 2026, supported by recent bookings and anticipated contract awards [7] Company Strategy and Development Direction - The company is focused on expanding capacity, developing new capabilities, and enhancing research and rapid prototyping [5][6] - Investments in capital improvements are expected to total approximately $2.4 million during fiscal year 2026 [5] - The company aims to broaden its addressable market and create additional revenue streams through new product lines [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to deliver sustainable growth and improving profitability [14] - The current backlog reflects stronger pricing and higher value programs, providing visibility into continued growth [13] - The company anticipates EBITDA improvement as margins recover and revenues increase [9] Other Important Information - The board approved a new stock repurchase program authorizing up to $10 million in common stock purchases [10] - The company has invested in additional machining and assembly equipment to support the XM30 vehicle program [12] Q&A Session Summary - No questions were received during the Q&A session, indicating a lack of immediate inquiries from participants [15]

Cisco Systems (NasdaqGS:CSCO) Q2 2026 Earnings call February 11, 2026 04:30 PM ET Speaker7Welcome to Cisco's second quarter fiscal year 2026 financial results conference call. At the request of Cisco, today's conference is being recorded. If you have any objections, you may disconnect. Now I would like to introduce Sami Badri, Head of Investor Relations. Sir, you may begin.Speaker9Good afternoon, everyone. This is Sami Badri, Cisco's Head of Investor Relations. I'm joined by Chuck Robbins, our Chair and CEO ...

CytomX Therapeutics (NasdaqGS:CTMX) 2026 Conference February 11, 2026 04:30 PM ET Company ParticipantsChris Ogden - CFOConference Call ParticipantsMichael Schmidt - Senior Biotech AnalystMichael Schmidtthis next fireside chat. My name is Michael Schmidt, Senior Biotech Analyst with Guggenheim, and it's my great pleasure to welcome Chris Ogden, Chief Financial Officer of CytomX. So CytomX is a new coverage here, new research coverage at Guggenheim for us. It's a story we're really excited about, especially t ...

McDonald’s (NYSE:MCD) Q4 2025 Earnings call February 11, 2026 04:30 PM ET Speaker13Hello, and welcome to McDonald's fourth quarter 2025 investor conference call. At the request of McDonald's Corporation, this conference is being recorded. Following today's presentation, there will be a question and answer session for investors. At that time, investors only may ask a question by pressing star one on their touchtone telephone. I would now like to turn the conference over to Mr. Dexter Congbalay, Vice Presiden ...